Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sweden pushes ahead with stem cell research

This article was originally published in Clinica

Executive Summary

The Swedish government yesterday decided to press ahead with a proposal to extend the scope for research involving stem cells. The government aims to amend existing legislation, in place since 1991, that only allows research involving fertilised human eggs for the purposes of improving reproductive medicine. There is as yet no move to amend the transplantation law to address the issue of the commercial distribution and handling of human biological material, but this may be considered at a later date, the government says.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT058628

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel